Renewal Windows and Penalties for Thai Medical Device Registrations
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
Q: When and how should renewals be handled in Thailand, and what happens if the window is missed?
1. Key takeaways
Renewals in Thailand are handled between 1 October and 31 December each year, submitted in the year the certificate expires, uniformly through the SKYNET system. Since July 2025 the Thai FDA has operated a unified renewal system under which the renewal of establishment licences and registration certificates is handled together. The window is unusually dangerous because the consequence of missing it is not a repair task but a direct interruption of business: the registration becomes invalid, and SKYNET closes the import clearance channel for that entry, so the product cannot clear customs. The closure is executed automatically by the system rather than by manual decision, which means there is no buffer of discretion to fall back on. Renewal should therefore be managed as a fixed company-level task, protected by calendar entries, layered reminders and cross-confirmation between the licence holder and the original manufacturer.
- One window, one system. Renewals run from 1 October to 31 December each year in the expiry year, handled in SKYNET.
- Unified renewal since July 2025. The Thai FDA merged the renewal handling of establishment licences and registration certificates into one system.
- Missing the window stops imports. Registration becomes invalid and SKYNET automatically closes the import clearance channel, with no manual buffer.
- A narrow remedy exists. Within one month after expiry, until 31 January of the following year, a remedy is possible by submitting an explanation of reasons and paying a daily penalty of about 500 to 1,000 THB per day depending on category.
- Documents depend on the original path. Full CSDT route renewals need no additional documents and take effect automatically upon payment, except HIV-related test kits which must attach an analysis report; Partial 1 / Partial 2 routes must supplement documents according to adverse events over the past five years.
- Renewal fees are modest. Import reference figures: establishment licence about 12,000 plus 4,000 THB, Class 4 about 20,000 THB, Class 2-3 about 10,000 THB, Class 1 about 1,000 THB, subject to the current official announcement.
2. Legal basis
The unified renewal arrangement dates from July 2025, when the Thai FDA established a single renewal system under which establishment licence and registration certificate renewals are handled together in the SKYNET system, within the annual window of 1 October to 31 December, submitted in the year the certificate expires. If the window is missed, two consequences follow: the registration becomes invalid, and SKYNET closes the import clearance channel for the entry, meaning the product cannot pass customs. Because this closure is executed automatically by the system, there is no discretionary buffer. A remedy remains available, but only within one month after expiry, until 31 January of the following year, and it requires submitting an explanation of reasons together with payment of a daily penalty of about 500 to 1,000 THB per day depending on the category. Beyond that point the only route is re-registration. The documentation required at renewal depends on the original registration path. Under the Full CSDT route no additional documents are needed and renewal takes effect automatically upon payment, with the exception of HIV-related test kits, which must attach an analysis report. Under the Partial 1 / Partial 2 routes, documents must be supplemented according to adverse events over the past five years: where there were no serious adverse events, a safety declaration of no serious adverse events is submitted; where serious adverse events occurred, the submission comprises a safety declaration, RMP 1/2 reports, an RMP 3 report and a product analysis report.
3. Expert insights
The reason this window deserves special vigilance is that the enforcement mechanism removes human judgement from the loop. The channel closure is performed by SKYNET automatically, not by an officer deciding case by case, so there is no one to appeal to for a few days of grace. This is also why renewal should be understood as a fixed task independent of product-side performance. Many companies sell well and have no adverse events at all, yet still lose their import channel because the October to December window was missed, making this the most avoidable and at the same time the most common type of accident in the Thai market. The exposure is asymmetric: the effort required to renew on time is small and routine, while the cost of missing it is a full stoppage of imports plus the penalty payment, and after the remedy window closes, re-registration entirely. Because both parties share the consequence, the practical estimate of risk should treat the licence holder and the original manufacturer as jointly responsible for the calendar, and the responsibility should be fixed in writing rather than left to goodwill between the parties.
4. Practical recommendations
- Put renewals into the company compliance calendar. This is a company-level calendar item, not any single person’s to-do list entry.
- Set three reminders. Suggested points are early September, early October and mid-November, so that the window cannot pass unnoticed.
- Apply double review at the licence holder. One responsible person from the licence holder and one from the original manufacturer confirm with each other, so that neither party can miss the window alone.
- Fix the duty in the service agreement. Provide that the licence holder must notify the original manufacturer in writing thirty days before the window opens, putting the responsibility onto the contract.
- Know your document set in advance. Full CSDT route renewals need nothing extra except the HIV-related test kit analysis report; Partial 1 / Partial 2 routes need declarations and reports matched to five years of adverse event history.
- Never rely on the remedy window. The 31 January remedy costs a daily penalty of about 500 to 1,000 THB per day and still requires an explanation of reasons; after it, only re-registration remains.
5. Verification checklist
- □ Thai FDA unified renewal system (from July 2025, handled in SKYNET)
- □ Window from 1 October to 31 December each year
- □ Overdue consequences: registration invalid plus SKYNET closing the import clearance channel
- □ Remedy period until 31 January of the following year, requiring an explanation of reasons and a daily penalty of about 500 to 1,000 THB per day depending on category
- □ Full CSDT route: automatic renewal upon payment (HIV test kits excepted, analysis report required)
- □ Partial 1 / Partial 2 routes: documents supplemented according to adverse events over the past five years (safety declaration, RMP 1/2, RMP 3, product analysis report)
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Thailand. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with the Thai FDA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us